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Several studies have suggested a strong epidemiologic association between Diabetes Mellitus
(DM) and Hepatitis C Virus (HCV) infection in some populations. However, the reasons why chronic HCV
infection is prevalent in DM remain unknown. Our aims were to determine the prevalence of HCV infection in
a population of Nigerian diabetics compared with the general population as well as assess the influence of sex
and age on HCV infection in the same diabetic population.
A total of 115 diabetic patients were compared with 2,301 blood donors matched by
recognized risk factors to acquire HCV infection. Serologic testing for anti HCV was done using a commercial
enzyme-linked immunosorbent assay (ELISA) kits.
Sixty (60) type 2 diabetic patients were males while fifty-five (55) were females. Their mean age was
55.4 ± 9 years and mean blood glucose level was 8.5mmol/l. One subject tested positive for HCV infection. The
control group consisted of 2,031 adults recruited from the blood donor's clinic. Forty five of them (2.2%) tested
positive for HCV.
Our preliminary results suggest a low sero-prevalence of HCV infection among our patients with
type 2 diabetes. Presently, routine screening for HCV infection in persons with diabetes may not be necessary.
INTRODUCTION
Diabetes mellitus is a major health problem world
wide, occurring in about 2-7% of the Nigerian
population. Type 2 diabetes mellitus probably
accounts for about 90-95% of all cases of diabetes
worldwide and the current diabetes epidemic is
attributable to rising cases of type 2 diabetes. As at
2000, there were 7.5 million estimated cases of
diabetes in the African continent. By 2030, this
figure is expected to rise to around 18.2 million.
HCV is also prevalent worldwide, and there have
been reports of its association with chronic disease of





The earliest evidence that Hepatitis C Virus (HCV)
infection may be associated with diabetes became
apparent during recruitment for antiviral clinical
trials when a considerable proportion of patients
with HCV infection had to be excluded because of
diabetes. The association of HCV infection and
diabetes has also been observed in cohorts of patients
with diabetes in some populations. The reason for
this association has not been fully elucidated but
there has been a suggestion that diabetes mellitus
5
6,7
Correspondence: Dr O.A Adegoke
E-mail: adego3@yahoo.com
may be an extrahepatic manifestation of chronic HCV
infection. In a previous study, 555 liver transplant
recipients without preexisting diabetes from three
U.S. centres were followed up for about 5years.
37.7% of the patients developed diabetes mellitus
with hepatitis C Virus (HCV) infection being one of
the most important risk factors.
Wh i l e th ese in ve s t i g a t i o ns s ug ges t an
epidemiological association between HCV infection
and type 2 diabetes, no large controlled studies have
been conducted to confirm this relationship. Even
though previous studies from Nigeria have
demonstrated HCV infection in patients with chronic
liver disease, only one to the best of our knowledge
has studied the relationship between HCV and
diabetes mellitus. None of the 90 diabetic patients in
that study tested positive for anti-HCV. We therefore
determined the sero prevalence of HCV infection in
our clinic patients with type 2 diabetes mellitus and
compared this with the general population.




This was a cross-sectional study of the sero-
prevalence of HCV infection in type 2 diabetic
patients. Patients were recruited from the diabetes
club as endocrine clinics
PATIENTSAND METHODS
Patient Selection
of the Obafemi Awolowo University Teaching
Hospital, Ile-Ife, South-western Nigeria. The
Teaching Hospital provides tertiary level health care
for the Ife-Ijesa zone of Osun State, while also
receiving referrals from adjoining states of Ondo
and Ekiti. About 200 diabetics attend the twice
weekly diabetes/endocrinology clinics run by two
specialist physicians.
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Participants were screened for HCV infection after
obtaining a verbal informed consent. The test was
performed with a second generation ELISA test
using Clinotech diagnostic Inc discs for detection
of antibodies to Hepatitis C. Four drops of serum are
put in an opening of the flat disc. The sample runs
through a panel to the opposite side that has been
colour-coded. One coloured band indicates a
negative result, two coloured band indicates a
positive result while no band or more than two bands
indicate an invalid result. Each test is self controlled.
Blood donors from the general population were
recruited and similarly screened for HCV
antibodies.
The percentage of subjects testing positive for HCV
and HBV were determined in both diabetics and
controls and then statistically compared. Other data
are presented as mean ± SD.
A total of one hundred and fifteen (115) patients
with diabetes comprising sixty (60) males and fifty
five (55) females were screened for antibodies to
hepatitis C. Their ages ranged from 35-80 years,
mean 55 ± 9 years. They had mean disease duration
of 5 years. 20(17.7%) of them were being treated
with insulin. Only one subject (0.8%) was positive
for hepatitis C Virus antibodies. 3 subjects (2.6%)
tested positive for hepatitis B Virus antibodies. A
total of 2,013 apparently healthy blood donors
(mean age 36 ± 5 years) were similarly screened. Of
these, 45 (2.2%) tested positive for HCV infection.
HCV sero-prevalence did not differ between the two
groups, p = 0.5132 Fishers exact test.
Our results suggest a low HCV sero prevalence
among an indigenous Nigerian diabetic population.
Though some data of interest such as history of
blood transfusion and liver histology were not
available, we are presenting perhaps one of the
earliest set of HCV sero-prevalence data amongst
diabetics in Nigeria.






frequency of HCV infection among patients with type
2 DM, in comparison with either the general
population or blood donors. In a study of 176
consecutive patients with diabetes and 6,172 blood
donors, Shintani et al, reported that 11.5% and 2.5%
of diabetics and blood donors respectively tested
positive for HCV infection. They concluded that
HCV may have a direct role in the development of
diabetes and that testing routinely for HCV infection
in diabetic patient should be mandatory. These sero
prevalence data should however be interpreted with
caution in view of the fact that diabetic patients have
an additional risk of developing HCV infection
because of compromised immunity and increased
e x p os u r e t o m ed i ca l i n t e r v en t i o n an d
instrumentation. Temporal effects of HCV infection
on diabetes and vice-versa may also be difficult to
demonstrate because of the insidious onset of both
disorders.
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It has also been observed that HCV does not
contribute significantly even to hepatic disease in
Nigeria. Ojo et al had previously reported that HCV
infection plays a very minor role in the pathogenesis
of chronic liver disease in Nigerian patients. Also, in
a study of biopsy proven cases of chronic hepatitis
patients, Ndububa et al screened 17 patients (9
males, 8 females) with only one testing positive for
HCV antibody. HBV Viral hepatitis is the most
common cause of chronic hepatitis world wide with
HBV predominating in sub-Saharan Africa and HCV
more prevalent in US and Europe. This may explain
in part the low sero-prevalence of HCV infection in
our type 2 diabetic patients.
Several possible mechanisms have been postulated to
link HCV to diabetes. Hepatitis C virus infection has
been shown to produce insulin resistance (because of
liberated cytokines), and insulin secretory defects (by
viral infection or auto-immune damage). Hepatitis
C virus infection also leads to non-alcoholic fatty
liver disease (a probable component of insulin
resistance syndrome) and increased iron increased
iron storage in the body. All these factors may
explain the contribution of hepatitis C virus infection
to the development of diabetes mellitus.
In concluding, our preliminary results suggest a low
sero-prevalence of HCV infection among our patients
with type 2 diabetes. Larger studies are needed to
answer this important question in our locality.
Perhaps, it may change our approach to managing this
common endocrine disorder. Presently routine
screening for HCV infection in persons with diabetes
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